CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | +100.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 188,703 | $557,000 | 0.43% |
| Sterling Financial Planning, Inc. | 22,031 | $65,000 | 0.05% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 165,495 | $488,000 | 0.04% |
| Ariel Investments | 821,096 | $2,422,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,287 | $445,000 | 0.01% |
| Renaissance Technologies | 675,159 | $1,992,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 781,891 | $2,299,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $9,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,018 | $310,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 53,441 | $157,000 | 0.00% |